KORU Medical Systems (KRMD) vs LENSAR (LNSR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
KORU Medical Systems (KRMD) has outperformed LENSAR (LNSR) over the past year, losing 28.4% versus a loss of 47.0%. Over five years, KRMD leads with a +4.5% price change compared with -14.2% for LNSR. KORU Medical Systems is the larger company by market cap ($137.3 million vs $80.4 million), about 1.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KRMD | LNSR |
|---|---|---|
| Share price | $2.99 | $6.54 |
| Market cap | $137.34M | $80.39M |
| 1-day change | -0.33% | +1.44% |
| YTD return | -48.36% | -44.54% |
| 1-year return | -28.40% | -47.04% |
| 5-year return | +4.53% | -14.23% |
| P/E ratio (TTM) | — | 36.35 |
| Forward P/E | 85.43 | — |
| EPS (TTM) | $-0.04 | $0.18 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.61 | $12.94 |
| 52-week low | $2.86 | $4.95 |
| Distance from 52-week high | -54.75% | -49.44% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +109.03% | +73.16% |
| Average volume | 235.20K | 102.04K |
| Shares outstanding | 45.93M | 12.29M |
| Employees | 73 | 150 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- KRMD has outperformed LNSR by 18.6 percentage points over the past year.
About KORU Medical Systems
KRMD stock →KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally.
Health Care · Medical/Dental Instruments · 73 employees
About LENSAR
LNSR stock →LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision.
Health Care · Medical/Dental Instruments · 150 employees
KRMD vs LNSR FAQ
Which is bigger, KORU Medical Systems or LENSAR?
KORU Medical Systems (KRMD) is larger, with a market capitalization of $137.34M compared with $80.39M for LENSAR (LNSR).
Which stock has performed better over the past year, KRMD or LNSR?
KRMD returned -28.40% over the past 12 months, compared with -47.04% for LNSR (price return, excluding dividends). Past performance does not predict future results.
Are KORU Medical Systems and LENSAR in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.